Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/37878Registo completo
| Campo DC | Valor | Idioma |
|---|---|---|
| dc.contributor.author | Rodrigues, Célia Fortuna | por |
| dc.contributor.author | Rodrigues, E. | por |
| dc.contributor.author | Silva, Sónia Carina | por |
| dc.contributor.author | Azeredo, Joana | por |
| dc.contributor.author | Henriques, Mariana | por |
| dc.date.accessioned | 2015-10-30T17:56:38Z | - |
| dc.date.available | 2015-10-30T17:56:38Z | - |
| dc.date.issued | 2015-10-09 | - |
| dc.identifier.citation | Rodrigues, Célia F.; Rodrigues, E.; Silva, Sónia Carina; Azeredo, Joana; Henriques, Mariana, How do Candida glabratas biofilms respond to antifungal drugs?. 7th Trends in Medical Mycology. Vol. Mycoses 58(Suppl. 4), Lisbon, Portugal, 9-12 Oct, 82-82, 2015. | - |
| dc.identifier.issn | 0933-7407 | por |
| dc.identifier.uri | https://hdl.handle.net/1822/37878 | - |
| dc.description.abstract | Candida species are responsible for recurrent human infections, mostly in immunocompromised patients, due to their high vulnerability. Candida glabrata has been shown to have a major role in these infections being the second most prevalent species involved in human fungemia. Objective: To understand the effect of three different antifungal agents Fluconazole (Flu), Amphotericin B (AmB) and Caspofungin (Csf) - in C. glabratas biofilm formation, specially their role on matrix composition. | por |
| dc.description.sponsorship | Programa Operacional, Fatores de competitividade – COMPETE and by national funds through FCT – Fundação para a Ciência e a Tecnologia on the scope of the projects FCT PTDC/SAU-MIC/119069/2010, RECI/EBB- EBI/0179/2012, PEst-OE/EQB/LA0023/2013 Project “BioHealth - Biotechnology and Bioengineering approachesto improvehealthquality",Ref. NORTE-07-0124-FEDER-000027, co-funded by the Programa Operacional Regional do Norte (ON.2 – O Novo Norte), QREN, FEDER | por |
| dc.language.iso | eng | por |
| dc.publisher | John Wiley and Sons | por |
| dc.relation | info:eu-repo/grantAgreement/FCT/5876-PPCDTI/119069/PT | - |
| dc.relation | info:eu-repo/grantAgreement/FCT/COMPETE/119069/PT | - |
| dc.relation | info:eu-repo/grantAgreement/FCT/5876-PPCDTI/126270/PT | - |
| dc.relation | info:eu-repo/grantAgreement/FCT/COMPETE/126270/PT | - |
| dc.relation | info:eu-repo/grantAgreement/FCT/3599-PPCDT/132966/PT | - |
| dc.rights | openAccess | por |
| dc.subject | Candida glabrata | por |
| dc.subject | Biofilms | por |
| dc.subject | Resistance Mechanisms | por |
| dc.subject | Antifungals | por |
| dc.subject | Matrix | por |
| dc.title | How do Candida glabrata´s biofilms respond to antifungal drugs? | por |
| dc.type | conferenceAbstract | - |
| dc.peerreviewed | yes | por |
| dc.relation.publisherversion | http://onlinelibrary.wiley.com/doi/10.1111/myc.12380/abstract | por |
| dc.comments | CEB23431 | por |
| sdum.publicationstatus | published | por |
| oaire.citationConferenceDate | 9 Out. - 12 Out. 2015 | por |
| sdum.event.type | conference | por |
| oaire.citationStartPage | 82 | por |
| oaire.citationEndPage | 82 | por |
| oaire.citationIssue | Suppl. 4 | - |
| oaire.citationConferencePlace | Lisbon, Portugal | por |
| oaire.citationTitle | 7th Trends in Medical Mycology | por |
| oaire.citationVolume | Mycoses 58 | - |
| dc.date.updated | 2015-10-14T20:52:10Z | - |
| dc.subject.fos | Ciências Médicas::Biotecnologia Médica | por |
| dc.subject.wos | Science & Technology | por |
| sdum.journal | Mycoses | por |
| Aparece nas coleções: | ||
Ficheiros deste registo:
| Ficheiro | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| document_23431_1.pdf | 107,9 kB | Adobe PDF | Ver/Abrir | |
| document_23431_2.pdf | 1,17 MB | Adobe PDF | Ver/Abrir |
